Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Total Liabilities : ¥1,248 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hubei Hongyuan Pharmaceutical Technology Co Total Liabilities?

Hubei Hongyuan Pharmaceutical Technology Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,248 Mil.

Hubei Hongyuan Pharmaceutical Technology Co's quarterly Total Liabilities increased from Sep. 2023 (¥1,190.48 Mil) to Dec. 2023 (¥1,290.93 Mil) but then declined from Dec. 2023 (¥1,290.93 Mil) to Mar. 2024 (¥1,247.75 Mil).

Hubei Hongyuan Pharmaceutical Technology Co's annual Total Liabilities increased from Dec. 2021 (¥754.27 Mil) to Dec. 2022 (¥1,761.52 Mil) but then declined from Dec. 2022 (¥1,761.52 Mil) to Dec. 2023 (¥1,290.93 Mil).

Hubei Hongyuan Pharmaceutical Technology Co Total Liabilities Historical Data

The historical data trend for Hubei Hongyuan Pharmaceutical Technology Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Hongyuan Pharmaceutical Technology Co Total Liabilities Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

855.41

576.27

754.27

1,761.52

1,290.93

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
	Jun15	Dec15	Jun16	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,571.63	1,373.43	1,190.48	1,290.93	1,247.75

Hubei Hongyuan Pharmaceutical Technology Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hubei Hongyuan Pharmaceutical Technology Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	914.828	+	(283.015	+	93.09
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,291

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	5650.771	-	4359.837
	=	1,291

Hubei Hongyuan Pharmaceutical Technology Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	875.871	+	(280.927	+	90.955
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,248

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	5640.263	-	4392.51
	=	1,248

Hubei Hongyuan Pharmaceutical Technology Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hubei Hongyuan Pharmaceutical Technology Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 8, Hongyuan Road, Economic Development Zone, Luotian County, Hubei Province, Fengshan Town, CHN, 438600

Website

http://www.hbhypharm.com

Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines

No Headlines